Blood cancer (ALL leukaemia)
A study to assess the benefit of targeted therapy during initial treatment and response-based consolidation in adolescents and young adults patients with acute lymphoblastic leukemia.
Who can joinChildren and adults
Age15–39 years
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Tata Memorial HospitalIndiaDirections ↗
Registry summary (technical)
A multicentre Phase III randomized control trial to test the efficacy of targeted agents during induction and a response adapted consolidation in adolescent and young adult patients with denovo ALL - TARGET
Sponsor: Dr Hasmukh Jain
CTRI/2025/03/082015 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 3 Aug 2026 · read by us 5 Nov 2026